SCH-50911 induces acute withdrawal syndrome in GHB-dependent rats, similar to the delirium tremens seen in human alcohol withdrawal, and can precipitate convulsions in GHB-dependent animals.
SCH-50911 triggers acute withdrawal symptoms in GHB-addicted rats, mirroring the delirium tremens experienced by humans undergoing alcohol withdrawal, and can induce seizures in GHB-dependent animals.